BNTC (Benitec Biopharma) Research & Development: $18.37 Mil (TTM As of Mar. 2026)


BNTC Benitec Biopharma Inc BNTC
34 GF Score
Price $13.07
View Full Analysis

What is Benitec Biopharma Research & Development?

Benitec Biopharma BNTC -4.49% 34 Research & Development is $18.37 Mil as of Mar. 2026. GuruFocus rates BNTC with a GF Score™ of 34/100.

Research & Development is the aggregate amount of research and development expenses during the year. Benitec Biopharma's Research & Development for the three months ended in Mar. 2026 was $6.30 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $18.37 Mil.

Benitec Biopharma  (NAS:BNTC) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Benitec Biopharma Research & Development Related Terms

Benitec Biopharma Research & Development Historical Data

* Premium members only.

The historical data trend for Benitec Biopharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Benitec Biopharma Research & Development Chart

Benitec Biopharma Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.02 11.27 12.77 15.61 18.33

Benitec Biopharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.50 2.87 3.37 5.83 6.30
BNTC
34GF Score
Benitec Biopharma Inc BNTC
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Benitec Biopharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.37 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $18.37 Mil mean?
Benitec Biopharma (BNTC) has a Research & Development of $18.37 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Benitec Biopharma and its competitors.
Is Benitec Biopharma's Research & Development too high?
Benitec Biopharma's current Research & Development is $18.37 Mil. Overall, Benitec Biopharma has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Benitec Biopharma's Research & Development compare to OABI and FBRX?
Benitec Biopharma's Research & Development of $18.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Benitec Biopharma and its competitors. Benitec Biopharma's current Research & Development is $18.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Benitec Biopharma stock overvalued right now?
Benitec Biopharma (BNTC) has a current Research & Development of $18.37 Mil. The current Research & Development is $18.37 Mil. Benitec Biopharma's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Benitec Biopharma (BNTC), the current Research & Development is $18.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Benitec Biopharma Business Description

Address 3940 Trust Way, Hayward, CA, USA, 94545
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
34GF Score

Get the complete analysis for BNTC

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.07
Price